What is Growth Strategy and Future Prospects of TELUS Company?

Combining dense mid-band 5G spectrum with fiber backhaul drives throughput and consistency for consumer and enterprise customers.

Network automation, AI-driven anomaly detection, and self-optimizing networks reduce faults and improve unit economics.

Trials of Open RAN and network slicing enable tailored SLAs for latency-sensitive industrial and enterprise use cases.

Private 5G and multi-access edge compute offerings support manufacturing, logistics, and healthcare latency requirements.

Clinical-grade virtual care workflows, benefits and claims automation, and pharmacy technology are developed in dedicated R&D centers.

GenAI-enabled bots, agent-assist tools, and data annotation reduce handling times and improve customer experience metrics.

Modest service revenue acceleration expected from wireless ARPU stabilization, roaming recovery and FWA growth, supported by ongoing fibre-to-the-home deployments.

Operating leverage should emerge as post-peak capex falls and cost discipline continues, improving margins and cash conversion.

Allocation focuses on network maintenance, selective M&A in health and digital services, and sustaining the dividend while reducing leverage.

TELUS typically offers a competitive dividend yield in the mid-single-digit to around 6%+ range depending on market conditions and share price.

Deleveraging supported by FCF improvement, lower capital intensity and working-capital normalization; management targets a gradual move toward net debt/EBITDA in the low-3x area.

Main sensitivities include wireless ARPU trends, fibre rollout costs, competitive pricing, regulatory developments and execution of health/CX integrations.

Price wars, richer handset subsidies and cableco/wireline challengers can pressure ARPU and margins; third-party internet access rules may compress retail economics. Mitigation: focus on premium network differentiation, segmented pricing and fiber-led churn reduction to protect lifetime value.

CRTC wholesale internet rate decisions, MVNO access rules and spectrum policy changes can reduce returns; evolving healthcare privacy mandates raise compliance costs for TELUS Health. Mitigation: proactive regulatory engagement, privacy-by-default product redesign and scenario planning in capital allocation.

Realizing TELUS Health synergies and restoring profitable growth at TELUS International amid GenAI disruption to traditional BPO is uncertain. Mitigation: target higher-margin verticals, deploy AI-enabled productivity, pursue selective M&A and institute cost resets.

Higher-for-longer interest rates raise interest expense and can constrain consumer spending and device upgrades; currency swings affect international earnings. Mitigation: staggered debt maturities, interest-rate hedging and disciplined capex prioritization.

Rapid shifts (Open RAN, edge computing) and elevated cyber threats—especially within health data ecosystems—pose operational and reputational risk. Mitigation: adopt zero-trust architecture, expand SOC capabilities and enforce robust third-party risk programs.

Recent progress: accelerated network build completion, a major health acquisition integrated and early deleveraging while maintaining dividend growth. Key monitors: competitive/regulatory moves in 2024–2025 and the pace of TELUS International’s recovery for the TELUS growth strategy and TELUS future prospects.